Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Yuyu Huang"'
Publikováno v:
Shipin gongye ke-ji, Vol 45, Iss 15, Pp 76-84 (2024)
In order to investigate the effect of curing time on the edible quality and oxidative characteristics of compound low-sodium yak meat products, in this experiment, complex low-sodium yak meat was selected to investigate the effects of curing time (12
Externí odkaz:
https://doaj.org/article/25bf953b6e9840f4b837ccfb35ff7d0b
Autor:
Zongqi He, Xiang Xu, Yugen Chen, Yuyu Huang, Bensheng Wu, Zhizhong Xu, Jun Du, Qing Zhou, Xudong Cheng
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-17 (2024)
Abstract Background Huangkui Lianchang Decoction (HLD) is a traditional Chinese herbal formula for treating ulcerative colitis (UC). However, its mechanism of action remains poorly understood. The Study aims to validate the therapeutic effect of HLD
Externí odkaz:
https://doaj.org/article/865c18a7883e45379a021f5d81089c91
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27805- (2024)
Background: Ulcerative colitis (UC) is an inflammatory bowel disease characterized by persistent colonic inflammation. Here, we performed a systematic analysis to gain better insights into UC pathogenesis. Methods: We analyzed two UC-related datasets
Externí odkaz:
https://doaj.org/article/084c66af791642bf9a9e834650ceedf5
Publikováno v:
BMC Medical Genomics, Vol 16, Iss 1, Pp 1-9 (2023)
Abstract Background This study aimed to investigate a causal relationship between IBD and multiple kidney diseases using two-sample Mendelian randomization (MR) analyses. Methods We selected a group of single nucleotide polymorphisms (SNPs) specific
Externí odkaz:
https://doaj.org/article/539d8020e0af49098f823ce1c906ebc8
Publikováno v:
Shipin gongye ke-ji, Vol 44, Iss 5, Pp 347-355 (2023)
The objective of this study was to investigate the effect of Rosa roxburghii Tratt aqueous extract (RRTAE) on protein and lipid oxidation of minced yak meat during storage. Compared with the blank control and positive control of 0.02% butylated hydro
Externí odkaz:
https://doaj.org/article/48c8bd917a35409592a0c76c38c5a71d
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Hearing loss affecting about 2/1000 newborns is the most common congenital disease. Genetic defects caused approximately 70% of patients who have non-syndromic hearing loss. We recruited 13 Chinese Han deafness families who tested negative for GJB2,
Externí odkaz:
https://doaj.org/article/08629ef3fd3840ab86e9557b36f571fe
Autor:
Zhipeng Zhang, Jide Liu, Chongwei Zhu, Yuyu Huang, Xinguang Wang, Yizhou Zhou, Jianjun Wang, Jinguo Li
Publikováno v:
Materials, Vol 16, Iss 8, p 3008 (2023)
A novel fourth-generation nickel-based single crystal superalloy was brazed with Co-based filler alloy. The effects of post-weld heat treatment (PWHT) on the microstructure and mechanical properties of brazed joints were investigated. The experimenta
Externí odkaz:
https://doaj.org/article/ba5b90223adf4483b44f96d773a1d2a2
Autor:
Lianhua Sun, Dekun Gao, Junmin Chen, Shule Hou, Yue Li, Yuyu Huang, Fabio Mammano, Jianyong Chen, Jun Yang
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 16 (2022)
Mutations in the GJB2 gene that encodes connexin 26 (Cx26) are the predominant cause of prelingual hereditary deafness, and the most frequently encountered variants cause complete loss of protein function. To investigate how Cx26 deficiency induces d
Externí odkaz:
https://doaj.org/article/5d32b36ce3f94bc6aadf20dc53d62ebd
Publikováno v:
Journal of Pharmacological Sciences, Vol 143, Iss 4, Pp 281-289 (2020)
FoxM1 is a transcriptional regulator involved in tumor development, pulmonary fibrosis, and cardiac fibrosis. However, its role in renal interstitial fibrosis (RIF) has yet to be elucidated. We established a TGF-β1-stimulated human proximal tubular
Externí odkaz:
https://doaj.org/article/34b51cda62d84a47993324e4d9d52261
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 128, Iss , Pp 110133- (2020)
Radiotherapy is an effective treatment for pancreatic cancer. However, radio-resistance often resulted in poor prognostic. Ibrutinib is an orally small molecule drug in B cell malignancies. Here, we investigated for the first time the effect of ibrut
Externí odkaz:
https://doaj.org/article/0570618e92624b8cb2e315924a12eadb